Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Parovis-LS Tablet ER

Prescription Icon
Prescription Required

Marketer

Adivis Pharma Pvt Ltd

Salt Composition

Paroxetine (12.5mg) + Clonazepam (0.25mg)

Overview Parovis-LS Tablet ER

Deprexis ER tablets, a prescription medication for depression, combine active ingredients to elevate mood by boosting brain neurotransmitters. This action also reduces excessive neuronal activity, promoting calmness. Deprexis ER can be administered with or without food, consistently at the same time daily for optimal blood levels. Adhere strictly to your doctor's prescribed dosage and duration, as this medication carries a risk of dependence. Avoid missed doses; if one is missed, take it immediately upon recall. Complete the entire course of treatment, even with improvement. Abrupt cessation should be avoided due to potential withdrawal effects. Common side effects include nausea, vomiting, confusion, memory problems, reduced libido, delayed ejaculation, dizziness, and drowsiness. Refrain from driving or mentally demanding tasks until the medication's effects are known. Report any unusual mood changes or worsening depression to your doctor immediately, as suicidal thoughts are a potential risk. Patients with liver conditions should exercise caution, and all other medications should be disclosed to your doctor, as interactions may reduce efficacy or alter the drug's action. Notify your doctor of pregnancy, pregnancy plans, or breastfeeding.

Uses of Parovis-LS Tablet ER

Major Depressive Disorder

Major Benefits of Parovis-LS Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Parovis-LS Extended-Release Tablets. Ingest the tablet whole; avoid chewing, crushing, or breaking it. While Parovis-LS ER may be administered with or without food, consistent timing is recommended.

Common Side effects of Parovis-LS Tablet ER:

  • Nausea
  • Vomiting
  • Diarrhea
  • Confusion
  • Memory impairment
  • Uncoordinated body movements
  • Drowsiness
  • Tiredness
  • Anorgasmia (decreased orgasm)
  • Low sexual desire
  • Delayed ejaculation

How to use Parovis-LS Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Parovis-LS Tablet ER whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, but consistency in timing is recommended.

How Parovis-LS Tablet ER works:

Extended-release Parovis-LS tablets contain a dual-drug formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Parovis-LS Tablet ER and alcohol is inadvisable.

PregnancyPregnancyUNSAFE

Use of Parovis-LS Extended-Release tablets is strongly contraindicated in pregnancy. Pregnant individuals should consult their physician; research in both animal models and pregnant women has revealed substantial adverse effects on fetal development.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Parovis-LS tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingUNSAFE

Driving ability may be impaired by the use of Parovis-LS Extended-Release Tablets due to potential side effects.

KidneyKidneySAFE IF PRESCRIBED

Extended-release Parovis-LS tablets appear to pose minimal risk for individuals with kidney impairment. Current evidence indicates dose modification may be unnecessary, though this requires individual assessment. Physician consultation is advised. Patients experiencing end-stage renal disease may experience significant drowsiness with Parovis-LS ER tablet use.

LiverLiverCAUTION

Extended-release Parovis-LS tablets require careful administration in individuals with hepatic impairment. Dosage modification of Parovis-LS extended-release tablets may be necessary. Physician consultation is advised.

What if you forget to take Parovis-LS Tablet ER :

Should you forget a Parovis-LS Extended-Release Tablet dose, administer it immediately upon recollection. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Parovis-LS Tablet ER

LabelValue
Addictive Affirmative.
Treatment Category Nervous System

FAQs on Parovis-LS Tablet ER

Extended-release Parovis-LS tablets can heighten the risk of suicidal ideation or behavior in certain individuals, particularly during the initial stages of therapy. Individuals with pre-existing mood or behavioral disturbances are at increased risk. Close monitoring for changes in mood or behavior is crucial, and any such alterations should be promptly reported to your physician. Adherence to scheduled follow-up appointments is essential.
Discontinue Parovis-LS Tablet ER only under your physician's guidance. Ceasing treatment abruptly may trigger severe withdrawal effects; therefore, continued use is advised even if you feel healthy. Your doctor will likely reduce your dosage incrementally.
Some individuals using Parovis-LS Tablet ER have reported weight increase. Maintaining a healthy diet and regular physical activity may mitigate this effect. Preventing weight gain is simpler than managing subsequent weight loss.
Indeed, Parovis-LS Extended-Release tablets may induce drowsiness. Refrain from driving, operating equipment, working at elevated heights, or engaging in hazardous activities until you ascertain the drug's effects on you.
Taking Parovis-LS Tablet ER may impact sexual function in both men and women. This medication could lead to reduced libido, erectile dysfunction (difficulty achieving or sustaining an erection), and anorgasmia (inability to reach orgasm). Decreased sexual satisfaction and discomfort during intercourse are also possible side effects. Report any such issues to your physician.
Avoid alcohol consumption while using Parovis-LS Tablet ER. Alcohol may worsen the drowsiness this medication causes.
Individual responses to medication vary. Typically, experiencing the complete effects of Parovis-LS Tablet ER requires several weeks, though some individuals notice improvement earlier. Allow sufficient time for Parovis-LS Tablet ER to exert its therapeutic action.
Maintain this medication within its original, sealed packaging. Follow the storage guidelines printed on the package or label. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and others.
Parovis-LS Tablet ER
99
MRP 121
18% off